KROS — Keros Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapMomentum Trap

Annual balance sheet for Keros Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	7.02	266	230	279	331
Net Total Accounts Receivable
Net Total Receivables	0.922	0.216	18.2	0	0.143
Prepaid Expenses
Total Other Current Assets
Total Current Assets	8.93	268	251	286	347
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	1.91	1.6	2.4	17.6	19.5
Long Term Notes Receivable
Other Long Term Assets
Total Assets	11	269	255	307	370
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	4.49	7.18	11.8	16.5	24.4
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	10.5	7.72	12.1	29.4	37.8
Redeemable Preferred Stock
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	0.495	262	243	277	332
Total Liabilities & Shareholders' Equity	11	269	255	307	370
Total Common Shares Outstanding